{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T15:39:36Z","timestamp":1783697976833,"version":"3.55.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["52373133"],"award-info":[{"award-number":["52373133"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006407","name":"Natural Science Foundation of Henan Province","doi-asserted-by":"publisher","award":["232300421044"],"award-info":[{"award-number":["232300421044"]}],"id":[{"id":"10.13039\/501100006407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017700","name":"Henan Provincial Science and Technology Research Project","doi-asserted-by":"publisher","award":["252102310360"],"award-info":[{"award-number":["252102310360"]}],"id":[{"id":"10.13039\/501100017700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017700","name":"Henan Provincial Science and Technology Research Project","doi-asserted-by":"publisher","award":["SBGJ202403045"],"award-info":[{"award-number":["SBGJ202403045"]}],"id":[{"id":"10.13039\/501100017700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jconrel.2025.114568","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T07:42:33Z","timestamp":1766389353000},"page":"114568","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Structurally-defined non-cationic docosahexaenoic acid based siRNA-micelles for safe and effective combinatorial glioblastoma therapy"],"prefix":"10.1016","volume":"391","author":[{"given":"Sen","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyu","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qimeng","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yibin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weimin","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongya","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2025.114568_bb0005","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3322\/caac.21613","article-title":"Management of glioblastoma: state of the art and future directions","volume":"70","author":"Tan","year":"2020","journal-title":"Cancer J. Clin."},{"key":"10.1016\/j.jconrel.2025.114568_bb0010","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1136\/jnnp-2012-302946","article-title":"The art of gene therapy for glioma: a review of the challenging road to the bedside","volume":"84","author":"Tobias","year":"2013","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jconrel.2025.114568_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114113","article-title":"RNAi-based therapeutics and tumor targeted delivery in cancer","volume":"182","author":"Kara","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2025.114568_bb0020","article-title":"Nucleic acid drug and delivery techniques for disease therapy: present situation and future prospect","volume":"2","author":"Wang","year":"2024","journal-title":"Intdiscip. Med."},{"key":"10.1016\/j.jconrel.2025.114568_bb0025","article-title":"Bio-nano toolbox for precision Alzheimer\u2019s disease gene therapy","volume":"36","author":"Liu","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2025.114568_bb0030","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1186\/s12951-023-02147-z","article-title":"Engineering siRNA therapeutics: challenges and strategies","volume":"21","author":"Ali Zaidi","year":"2023","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2025.114568_bb0035","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.tibtech.2018.01.006","article-title":"Nanotechnology-based strategies for siRNA brain delivery for disease therapy","volume":"36","author":"Zheng","year":"2018","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.jconrel.2025.114568_bb0040","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201903277","article-title":"ROS-responsive polymeric siRNA nanomedicine stabilized by triple interactions for the robust glioblastoma combinational RNAi therapy","volume":"31","author":"Zheng","year":"2019","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2025.114568_bb0045","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jconrel.2018.10.034","article-title":"Boosting RNAi therapy for orthotopic glioblastoma with nontoxic brain-targeting chimaeric polymersomes","volume":"292","author":"Shi","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114568_bb0050","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abc7031","article-title":"Blood-brain barrier-penetrating siRNA nanomedicine for Alzheimer's disease therapy","volume":"6","author":"Zhou","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2025.114568_bb0055","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/s41565-024-01769-0","article-title":"Polymer-locking fusogenic liposomes for glioblastoma-targeted siRNA delivery and CRISPR-Cas gene editing","volume":"19","author":"Zhao","year":"2024","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2025.114568_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121645","article-title":"An optimized ionizable cationic lipid for brain tumor-targeted siRNA delivery and glioblastoma immunotherapy","volume":"287","author":"Liu","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2025.114568_bb0065","doi-asserted-by":"crossref","first-page":"7962","DOI":"10.1002\/adma.201600634","article-title":"Self-sealing porous silicon-calcium silicate core-shell nanoparticles for targeted siRNA delivery to the injured brain","volume":"28","author":"Kang","year":"2016","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2025.114568_bb0070","article-title":"siRNA nanoparticle suppresses drug-resistant gene and prolongs survival in an orthotopic glioblastoma xenograft mouse model","volume":"31","author":"Wang","year":"2021","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2025.114568_bb0075","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1021\/acs.nanolett.9b04683","article-title":"Charge conversional biomimetic nanocomplexes as a multifunctional platform for boosting orthotopic glioblastoma RNAi therapy","volume":"20","author":"Liu","year":"2020","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2025.114568_bb0080","doi-asserted-by":"crossref","first-page":"6345","DOI":"10.1002\/adma.201600554","article-title":"Traceable nanoparticle delivery of small interfering RNA and retinoic acid with temporally release ability to control neural stem cell differentiation for Alzheimer's disease therapy","volume":"28","author":"Zhang","year":"2016","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2025.114568_bb0085","doi-asserted-by":"crossref","first-page":"11449","DOI":"10.1073\/pnas.1411393111","article-title":"Correlating animal and human phase Ia\/Ib clinical data with CALAA-01, a targeted, polymer-based nanoparticle containing siRNA","volume":"111","author":"Zuckerman","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2025.114568_bb0090","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jconrel.2006.04.014","article-title":"Toxicity of cationic lipids and cationic polymers in gene delivery","volume":"114","author":"Lv","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114568_bb0095","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0142-9612(02)00445-3","article-title":"In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis","volume":"24","author":"Fischer","year":"2003","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2025.114568_bb0100","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1038\/s41587-020-0725-7","article-title":"Big pharma buys into exosomes for drug delivery","volume":"38","author":"Zipkin","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2025.114568_bb0105","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/s41551-018-0240-z","article-title":"Efficient siRNA delivery with non-cationic carriers","volume":"2","author":"Choi","year":"2018","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2025.114568_bb0110","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1073\/pnas.1200718109","article-title":"Polycation-siRNA nanoparticles can disassemble at the kidney glomerular basement membrane","volume":"109","author":"Zuckerman","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2025.114568_bb0115","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202000416","article-title":"Single siRNA nanocapsules for effective siRNA brain delivery and glioblastoma treatment","volume":"32","author":"Zou","year":"2020","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2025.114568_bb0120","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202418053","article-title":"Engineered bacterial outer membrane vesicles-based doxorubicin and CD47-siRNA co-delivery nanoplatform overcomes immune resistance to potentiate the immunotherapy of glioblastoma","volume":"37","author":"You","year":"2025","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2025.114568_bb0125","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jconrel.2022.11.036","article-title":"siRNA delivery to lymphatic endothelial cells via ApoE-mediated uptake by lipid nanoparticles","volume":"353","author":"Sakurai","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114568_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113764","article-title":"Polymersome-enabled brain codelivery of STAT3 siRNA and CpG oligonucleotide boosts chemo-immunotherapy of malignant glioma","volume":"383","author":"Zhao","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114568_bb0135","doi-asserted-by":"crossref","first-page":"5687","DOI":"10.1038\/s41467-020-19225-7","article-title":"Systemic brain tumor delivery of synthetic protein nanoparticles for glioblastoma therapy","volume":"11","author":"Gregory","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.114568_bb0140","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1021\/acsnano.1c05505","article-title":"Immune checkpoint inhibition in GBM primed with radiation by engineered extracellular vesicles","volume":"16","author":"Tian","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.114568_bb0145","doi-asserted-by":"crossref","first-page":"32965","DOI":"10.1021\/jacs.4c08990","article-title":"Facile alkyne assembly-enabled functional Au nanosheets for photoacoustic imaging-guided photothermal\/gene therapy of orthotopic glioblastoma","volume":"146","author":"Hu","year":"2024","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2025.114568_bb0150","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkaf270","article-title":"Conjugation to a transferrin receptor 1-binding bicycle peptide enhances ASO and siRNA potency in skeletal and cardiac muscles","volume":"53","author":"\u00d8stergaard","year":"2025","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jconrel.2025.114568_bb0155","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.jconrel.2021.07.048","article-title":"Selective transferrin coating as a facile strategy to fabricate BBB-permeable and targeted vesicles for potent RNAi therapy of brain metastatic breast cancer in vivo","volume":"337","author":"Wei","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114568_bb0160","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3006839","article-title":"Spherical nucleic acid nanoparticle conjugates as an RNAi-based therapy for glioblastoma","volume":"5","author":"Jensen","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2025.114568_bb0165","doi-asserted-by":"crossref","first-page":"7625","DOI":"10.1073\/pnas.1305804110","article-title":"Mechanism for the endocytosis of spherical nucleic acid nanoparticle conjugates","volume":"110","author":"Choi","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2025.114568_bb0170","doi-asserted-by":"crossref","first-page":"9702","DOI":"10.1002\/anie.202002312","article-title":"Organic spherical nucleic acids for the transport of a NIR-II-emitting dye across the blood-brain barrier","volume":"59","author":"Xiao","year":"2020","journal-title":"Angew. Chem. Int. Ed. Eng."},{"key":"10.1016\/j.jconrel.2025.114568_bb0175","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abb3945","article-title":"A first-in-human phase 0 clinical study of RNA interference-based spherical nucleic acids in patients with recurrent glioblastoma","volume":"13","author":"Kumthekar","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2025.114568_bb0180","article-title":"Cation-free siRNA micelles as effective drug delivery platform and potent RNAi nanomedicines for glioblastoma therapy","volume":"33","author":"Jiang","year":"2021","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2025.114568_bb0185","doi-asserted-by":"crossref","DOI":"10.1002\/alz.082650","article-title":"Interim phase 1 part a results for ALN-APP, the first investigational RNAi therapeutic in development for alzheimer\u2019s disease","volume":"19","author":"Cohen","year":"2023","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.jconrel.2025.114568_bb0190","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1038\/s41587-022-01334-x","article-title":"Expanding RNAi therapeutics to extrahepatic tissues with lipophilic conjugates","volume":"40","author":"Brown","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2025.114568_bb0195","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3390\/nu8010006","article-title":"DHA effects in brain development and function","volume":"8","author":"Lauritzen","year":"2016","journal-title":"Nutrients"},{"key":"10.1016\/j.jconrel.2025.114568_bb0200","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/s41551-018-0234-x","article-title":"Micelles with ultralow critical micelle concentration as carriers for drug delivery","volume":"2","author":"Lu","year":"2018","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2025.114568_bb0205","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1021\/nl802958f","article-title":"Polyvalent DNA nanoparticle conjugates stabilize nucleic acids","volume":"9","author":"Seferos","year":"2009","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2025.114568_bb0210","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.addr.2019.05.004","article-title":"Strategies, design, and chemistry in siRNA delivery systems","volume":"144","author":"Dong","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2025.114568_bb0215","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925011824?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925011824?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T08:37:41Z","timestamp":1781771861000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365925011824"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":43,"alternative-id":["S0168365925011824"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114568","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structurally-defined non-cationic docosahexaenoic acid based siRNA-micelles for safe and effective combinatorial glioblastoma therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114568","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114568"}}